CDKN2A and neoplasm: As previously described, five of the selected patients had a personal history of previous neoplastic disease, and, notably, about two-thirds of these individuals exhibited a heavy mutational load in both TP53 and CDKN2A tumor suppressor genes (see Figure 1).